A Randomized Controlled Trial of Rituximub versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (IMN)

Grant

Awarded By

Total Award Amount

  • 106731.00

    • Direct Costs

  • 84709.00

    • Sponsor Award Id

    • Contributor

  • Dana Rizk   Principal Investigator